Jennifer Lee

Jennifer Lee currently serves on the Advisory Board for BrightEdge at the American Cancer Society, focusing on enhancing support for entrepreneurs. As the Senior Vice President of Clinical Operations and Quality Assurance at Novita Pharmaceuticals and the Chief Executive Officer of JLC Life Sciences since 2018, Jennifer leads initiatives in clinical and regulatory strategy, business turnaround, and product development. Additionally, Jennifer holds multiple board positions and partnerships, including roles at Enzyme by Design, How Women Lead, and CANCER FUND, where expertise is applied to cancer investments and early-stage venture capital. With an academic background in clinical research and regulatory administration from Northwestern University and biochemistry from the University of Illinois Chicago, Jennifer also engages as a keynote speaker on topics related to life sciences and venture capital.